Journal profile · Chemical Engineering-Bioengineering
Tissue Engineering Part A
ISSN 1937-3341 · eISSN 1937-335X · Mary Ann Liebert Inc. · United States
Tissue Engineering Part A: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.79; hybrid open access; review about 3 months (community reports); community-reported acceptance: easy; 86 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Tissue Engineering Part A is published by Mary Ann Liebert Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tissue Engineering and Regenerative Medicine, Electrospun Nanofibers in Biomedical Applications and Mesenchymal stem cell research, together about 37.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.
Source: LetPub
Research area (LetPub): Chemical Engineering-Bioengineering
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tissue Engineering and Regenerative MedicineMedicine14.3%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science11.7%
- Mesenchymal stem cell researchMedicine11%
- Bone Tissue Engineering MaterialsEngineering9.8%
- Osteoarthritis Treatment and MechanismsMedicine7.5%
- 3D Printing in Biomedical ResearchEngineering7.4%
- Periodontal Regeneration and TreatmentsMedicine6.8%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
| Minor | Materials Science, Biomaterials | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 3 |
| Minor | Materials Science, Biomaterials | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.79LetPub ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 0.7LetPub ·
- SNIP 2026-06
- 0.71LetPub ·
- h-index
- 98LetPub ·
- h-index
- 154OpenAlex ·
- i10-index
- 2,904OpenAlex ·
- 2-year mean citedness
- 2.62OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 7.41%LetPub ·
Volume
- Articles per year
- 73LetPub ·
Articles by year OpenAlex count · 3,663 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 1 | 5 |
| 2025 | 86 | 27 | 106 |
| 2024 | 90 | 41 | 382 |
| 2023 | 91 | 27 | 699 |
| 2022 | 64 | 30 | 775 |
| 2021 | 81 | 39 | 1,221 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- United States
- Language
- English
- ISSN
- 1937-3341
- Electronic ISSN
- 1937-335X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Tissue Engineering Part A
What CAS zone is Tissue Engineering Part A in?
In the 2025 upgraded edition of the CAS Journal Ranking, Tissue Engineering Part A is in Zone 3 of Medicine, and in Zone 3 of the minor category Cell Biology / Engineering, Biomedical / Cell & Tissue Engineering / Materials Science, Biomaterials. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Tissue Engineering Part A?
The latest impact factor listed by LetPub is 2.79; CiteScore 5.9, h-index 154.
How long does peer review take at Tissue Engineering Part A?
Authors report an average review time of about 3 months; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Tissue Engineering Part A?
According to LetPub and DOAJ records, Tissue Engineering Part A is indexed in SCIE and Scopus.
Is Tissue Engineering Part A open access, and what is the APC?
Tissue Engineering Part A is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .